Brief: PCI Biotech: US Patent For The Vaccine Technology To Be Granted In April
March 26 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH: US PATENT FOR THE VACCINE TECHNOLOGY
(FIMAVACC)
WITH A NEW IMPORTANT CLASS OF ADJUVANTS
* NEW US PATENT WILL BE GRANTED EARLY APRIL 2020
* US PATENT COVERS USE OF FIMAVACC IN COMBINATION WITH A NEW
IMPORTANT CLASS OF VACCINE ADJUVANTS
Source text for Eikon: ID:nGNEpLdbV
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process